Long COVID: Evaluation of Physical and Functional Status

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

With more than 246 million people diagnosed with coronavirus 2019 (COVID-19) around the world, many of whom have required medical attention for past 23 months, greater emphasis is being placed on post-acute care of COVID-19 survivors. According to recent data, millions of patients who have recovered from acute COVID-19 are experiencing persistent symptoms, which lead to disability and impaired activities of daily living. Various terms have been used to describe the condition of patients who do not return to their initial health status to include post-acute sequelae of COVID-19, such as post-acute COVID syndrome (PACS) and Long COVID. The growing global burden of COVID-19 suggests that the potential effects of Long COVID in public health are vast even if Long COVID is experienced by a small proportion of patients recovering from acute infection. The ability to identify patients at high risk for Long COVID and forecasting medical resource requirements is of important clinical utility in the present. In view of the large number of people surviving after infection with COVID-19 and that should require follow-up, determine which patients are at risk of have Long COVID and who require close monitoring is crucial. In this study, therefore, we set out to analyze what type of patient profile with COVID-19 who, after 12 weeks of having suffered the infection, experiences the signs and symptoms described by current literature.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Have been positive for COVID-19 since the declaration of the state of alarm throughout the Spanish territory to deal with the health emergency situation caused by COVID-19 (March 14, 2020).

• Symptoms associated with COVID-19 at least after 12 weeks of its detection.

• Adequate cognitive and physical level to understand and perform the tests evaluation.

Locations
Other Locations
Spain
University of Las Palmas de Gran Canaria
RECRUITING
Las Palmas De Gran Canaria
Contact Information
Primary
Aníbal Báez Suárez, PhD
anibal.baez@ulpgc.es
+34652077692
Time Frame
Start Date: 2022-03-22
Estimated Completion Date: 2026-05-01
Participants
Target number of participants: 600
Treatments
Long COVID
Participants will self-complete some questionnaires, while the rest of the variables will be evaluated by the evaluating physiotherapist.~After the consultation, the evaluator himself will provide the participants with some recommendations that he should make. As support, a diptych has been made with different general activities to be developed by the participant. With the purpose of track this activity, they will be informed that they will be contacted once 6 months have passed since the evaluation (via phone call or SMS).
Related Therapeutic Areas
Sponsors
Leads: University of Las Palmas de Gran Canaria

This content was sourced from clinicaltrials.gov

Similar Clinical Trials